SARM1 orthosteric base exchange inhibitors cause subinhibitory SARM1 activation
Leahey, R.; Weber, M.; Cho, C. H.; Hur, S.; Cramer, A.; Manzanares, K.; Babin, B.; Boenig, G.; Kring, T.; Liu, L.; Cui, Y.; Ganti, A.; Evans, J. P.; Nespi, M.; Ly, J.; Nugent, A. A.; Green, S.; Chan, B.; Hoogenraad, C. C.; Delwig, A.; Hinz, F. I.
Show abstract
SARM1, an octameric NADase, is a key regulator of axon degeneration and an emerging target in small molecule drug discovery to treat a wide range of neurodegenerative diseases. Recently, a structurally diverse series of adduct-forming, orthosteric SARM1 inhibitors have been discovered. Here, we show that subinhibitory concentrations of these orthosteric inhibitors, under mildly SARM1 activating conditions, cause sustained SARM1 activation. This synergistic adverse effect leads to increased nicotinamide adenine dinucleotide (NAD) consumption, neurodegeneration and release of the biomarker neurofilament-light (NfL) in cultured cortical neurons. In two distinct animal models, we found that low-dose treatment with these orthosteric SARM1 inhibitors results in increased plasma NfL and adverse events when combined with cellular stress or injury conditions. This may present a critical liability for orthosteric SARM1 inhibitors in certain patient populations.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode 95%
- Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology 94%
- Functional identification of soluble uric acid as an endogenous inhibitor of CD38 94%
Similar papers in this journal
- Targeting transcription factors through an IMiD independent zinc finger domain 96%
- Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression 95%
- Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile 94%
Similar papers in this journal
- Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma 95%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 95%
- Endogenous formaldehyde scavenges cellular glutathione resulting in cytotoxic redox disruption 94%
Similar papers in this journal
- Nicotinic acetylcholine receptor partial antagonist polyamides from tunicates and their predatory sea slugs 96%
- Exifone is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration 94%
- Sigma receptor ligands are potent anti-prion compounds that act independently of sigma receptor binding 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.